RxGenomix strives to be the leader in empowering healthcare providers to put the power of pharmacogenomics to work for their patients. That’s why we started by creating the 16-hour RxGenomix Training Program in Pharmacogenomics in collaboration with Manchester University’s College of Pharmacy, Natural & Health Sciences and offer it through a joint providership with CEI.
The course is designed to give a solid understanding of the basics of the essential science and how to implement it in clinical practice. However, we don't stop there. RxGenomix has a wide range of training tools and works closely with all members of the care team from physicians and pharmacists to medical staff and benefit administrators to make sure they have all they need to do their part and help provide the best care possible.
The Training Program in Pharmacogenomics was designed to give working pharmacists and students the opportunity to attain the competencies set out by both the ACPE Standards and the Genetics/Genomics Competency Center. The course will make it possible for pharmacists to apply a pharmacogenomic testing program to their own practice and work with the prescriber to create a truly personal medication therapy plan.
CEI is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). The following course is approved for 16.0 contact hour of CPE credit (1.6 CEUs). The ACPE Universal Activity Number for this activity is: 0107-9999-19-337-H01-P (pharmacists).
Available: October 26, 2019
Expiration Date: October 25, 2022
To obtain 16.0 contact hours of CPE credit for completing this course, “Pharmacogenomics,” participants must pre-register online, participate in the entire course, pass the final exam with a score of at least 70%, and complete the CPE assessment and evaluation questions.
ON DEMAND: To obtain 16.0 contact hours of continuing pharmacy education credit (1.6 CEUs), participants must pre-register for the course on the RxGenomix website (rxgenomix.com), complete the entire on-demand course, and pass the mid and final exams with scores of at least 70%. Once completed, you will receive a code from RxGenomix and instructions on how to access the evaluation on the CEImpact LMS . Once the evaluation is successfully completed, click the Submit button. The CPE Statement of Credit can then be accessed on CPE Monitor, www.MyCPEMonitor.net.
Knowledge-based
There is a fee of $349 associated with this activity.
“Pharmacogenomics” is a home study continuing education activity for pharmacists developed by RxGenomix.
The RxGenomix learning portal is designed to work with any current web browser. If you have any technical difficulties, please contact RxGenomix: info@rxgenomix.com. For best results, the following system capabilities are recommended:
David Bright, PharmD, BCACP
Associate Professor of Pharmacy
Ferris State University
David Kisor, BS, PharmD, FCP
Professor of Pharmaceutical Sciences and Pharmacogenomics
Manchester University
Director of Pharmacogenomics Programs
Manchester University
Brad Tice, PharmD, MBA, FAPhA
Founder and Shareholder, RxGenomix
David Bright, PharmD, BCACP declares financial interests for the following:
Relationship | Name of Commercial Interest | Received |
---|---|---|
Co-investigator | Genemarkers, LLC | Honorarium |
Principal Investigator | RiteAid | Funded research |
David Kisor, BS, PharmD, FCP declares financial interests for the following:
Relationship | Name of Commercial Interest | Received |
---|---|---|
PGx Education Consultant | PWN Health, LLC | Consulting fee |
Brad Tice, PharmD, MBA, FAPhA declares financial interests for the following:
Relationship | Name of Commercial Interest | Received |
---|---|---|
Founder | RxGenomix, LLC | Shareholder |
At the completion of this activity, pharmacists and pharmacy technicians will be able to: